SerruysPWde JaegerePKiemeneijF. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med.1994;331:489–495.
2.
FischmanDLLeonMBBaimDS. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med.1994;331:496–501.
3.
Al SuwaidiJHolmesDRSalamAM. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J.2004;147:815–822.
4.
SerruysPWFoleyDPSuttorpMJ. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. JAm Coll Cardiol. 2002;39:393–399.
5.
TanKSulkeNTaubN. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol. 1995;25:855–865.
6.
EllisSGRoubinGSKingSB. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation. 1988;77:372–379.
7.
AkiyamaTMoussaIReimersB. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. JAm Coll Cardiol. 1998;32:1610–1618.
8.
MorenoRFernandezCAlfonsoF. Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. J Am Coll Cardiol. 2004;43:1964–1972.
9.
SavageMPDouglasJSJrFischmanDL. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med.1997;337:740–747.
10.
KeeleyECVelezCAO'NeillWW. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. JAm Coll Cardiol. 2001;38:659–665.
11.
EllisSGBrenerSJDeLucaS. Late myocardial ischemic events after saphenous vein graft intervention—importance of initially “nonsignificant” vein graft lesions. Am J Cardiol. 1997;79:1460–1464.
12.
Le MayMRLabinazMMarquisJF. Predictors of long-term outcome after stent implantation in a saphenous vein graft. Am J Cardiol. 1999;83:681–686.
13.
DoorisMSafianRD. Coronary artery bypass grafts. In: FreedMGrinesCSafianRD, eds. The Manual of Interventional Cardiology. Birmingham: Physician's Press; 2001:317–356.
14.
IakovouIDangasGMintzGS. Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome. Am J Cardiol. 2004;93:963–968.
15.
BaimDSWahrDGeorgeB. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285–1290.
16.
SrinivasVSBrooksMMDetreKM. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study. Circulation. 2002;106:1627–1633.
17.
RodriguezABernardiVNaviaJ. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. JAm Coll Cardiol. 2001;37:51–58.
18.
SerruysPWUngerFSousaJE. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med.2001;344:1117–1124.
19.
SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360:965–970.
20.
GoldbergSLColomboANakamuraS. Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol. 1994;24:996–1003.
21.
NakamuraSColomboAGaglioneA. Intracoronary ultrasound observations during stent implantation. Circulation. 1994;89:2026–2034.
22.
CollerBSPeerschkeEIScudderLE. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest. 1983;72:325–338.
23.
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med.1994;330:956–961.
24.
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med.1997;336:1689–1696.
25.
BalsanoFVioliFCimminielloC. Ticlopidine in unstable angina. Circulation. 1990;82:2282–2283.
26.
BarraganPSainsousJSilvestriM. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn. 1994;32:133–138.
27.
ColomboAHallPNakamuraS. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676–1688.
28.
SchomigANeumannFJKastratiA. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med.1996;334:1084–1089.
29.
MoriceMC. Chronology of use of ticlopidine to prevent stent occlusion. Circulation. 1998;98:2101.
30.
KarrillonGJMoriceMCBenvenisteE. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30–day clinical outcome of the French Multicenter Registry. Circulation. 1996;94:1519–1527.
31.
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet. 1998;352:87–92.
32.
AbizaidASMintzGSMehranR. Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. Circulation. 1999;100:256–261.
33.
LanskyAPopmaJJ. Qualitative and quantitative angiography. In: TopolEJ, ed. Textbook of Interventional Cardiology. 3rd ed.Philadelphia: WB Saunders; 1999:725–747.
34.
IakovouIMintzGSDangasG. Increased CK-MB release is a “trade-off” for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2003;42:1900–1905.
35.
IakovouIMintzGSDangasG. Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. Am J Cardiol. 2003;92:1171–1176.
36.
OemrawsinghPVMintzGSSchalijMJ. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation. 2003;107:62–67.
37.
SimpsonJB. How atherectomy began: a personal history. Am J Cardiol. 1993;72:3E–5E.
38.
TopolEJLeyaFPinkertonCA. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med.1993;329:221–227.
39.
AdelmanAGCohenEAKimballBP. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med.1993;329:228–233.
40.
AhmedJMHongMKMehranR. Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes. J Am Coll Cardiol. 2000;35:1560–1568.
41.
HolmesDRGarrattKNIsnerJM. Effect of subintimal resection on initial outcome and restenosis for native coronary lesions and saphenous vein graft disease treated by directional coronary atherectomy. A report from the CAVEAT I and II investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. J Am Coll Cardiol. 1996;28:645–651.
42.
LefkovitsJHolmesDRCaliffRM. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Coronary Angioplasty Versus Excisional Atherectomy Trial. Circulation. 1995;92:734–740.
43.
BaimDSCutlipDESharmaSK. Final results of the Balloon vs Optimal Atherectomy Trial (BOAT). Circulation. 1998;97:322–331.
44.
StankovicGColomboABersinR. Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing. Am J Cardiol. 2004;93:953–958.
45.
MoussaIDi MarioCMosesJ. Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results. Circulation. 1997;96:128–136.
46.
KobayashiYDe GregorioJKobayashiN. Lower restenosis rate with stenting following aggressive versus less aggressive rotational atherectomy. Catheter Cardiovasc Interv. 1999;46:406–414.
47.
MacIsaacAIBassTABuchbinderM. High speed rotational atherectomy: outcome in calcified and noncalcified coronary artery lesions. J Am Coll Cardiol. 1995;26:731–736.
48.
WarthDCLeonMBO'NeillW. Rotational atherectomy multicenter registry: acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol. 1994;24:641–648.
49.
UmansVAStraussBHRensingBJ. Comparative angiographic quantitative analysis of the immediate efficacy of coronary atherectomy with balloon angioplasty, stenting, and rotational ablation. Am Heart J.1991;122:836–843.
50.
WhitlowPLBassTAKippermanRM. Results of the study to determine Rotablator and transluminal angioplasty strategy (STRATAS). Am J Cardiol. 2001;87:699–705.
51.
BuchbinderMFortunaRSharmaS. Debulking prior to stenting improves acute outcomes: early results from the SPORT trial [Abstract]. J Am Coll Cardiol. 1988;35(Suppl a):8A.
52.
BurzottaFTraniCPratiF. Comparison of outcomes (early and six-month) of direct stenting with conventional stenting (a meta-analysis of ten randomized trials). Am J Cardiol. 2003;91:790–796.
53.
SerruysPWIjsselmuidenSHoutB. Direct stenting with the Bx VELOCITY balloon-expandable stent mounted on the Raptor rapid exchange delivery system versus predilatation in a European randomized Trial: the VELVET trial. Int J Cardiovasc Intervent. 2003;5:17–26.
54.
RaghuCLoubeyreCObadiaE. Primary angioplasty in CADASIL. Catheter Cardiovasc Interv. 2003;59:235–237.
55.
FitzgeraldPJOshimaAHayaseM. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation. 2000;102:523–530.
56.
ColomboADe GregorioJMoussaI. Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions. J Am Coll Cardiol. 2001;38:1427–1433.
57.
TeirsteinPSMassulloVJaniS. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med.1997;336:1697–1703.
58.
PopmaJJSuntharalingamMLanskyAJ. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 2002;106:1090–1096.
59.
PopmaJJKuntzREBaimDS. A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease. Circulation. 2002;106:1592–1594.
60.
SerruysPWSianosGvan der GiessenW. Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study. Eur Heart J.2002;23:1351–1359.
61.
VerinVPopowskiYde BruyneB. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med.2001;344:243–249.
62.
YoshimotoY. Publication bias in neurosurgery: lessons from series of unruptured aneurysms. Acta Neurochir (Wien). 2003;145:45–48.
63.
GrinesCPatelAZijlstraF. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J.2003;145:47–57.
64.
GrzybowskiMClementsEAParsonsL. Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis. JAMA. 2003;290:1891–1898.
65.
O'NeillWWDixonSR. The year in interventional cardiology. J Am Coll Cardiol. 2004;43:875–890.
66.
AndersenHRNielsenTTRasmussenK. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med.2003;349:733–742.
67.
WidimskyPBudesinskyTVoracD. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial—PRAGUE-2. Eur Heart J.2003;24:94–104.
68.
SchomigANdrepepaGMehilliJ. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation. 2003;108:1084–1088.
69.
DalbyMBouzamondoALechatP. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation. 2003;108:1809–1814.
70.
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994;89:1545–1556.
71.
BodenWEO'RourkeRACrawfordMH. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med.1998;338:1785–1792.
72.
McCulloughPAO'NeillWWGrahamM. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. JAm Coll Cardiol. 1998;32:596–605.
73.
Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study.FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet. 1999;354:708–715.
74.
CannonCPWeintraubWSDemopoulosLA. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med.2001;344:1879–1887.
75.
FoxKAPoole-WilsonPAHendersonRA. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet. 2002;360:743–751.
76.
NeumannFJKastratiAPogatsa-MurrayG. Evaluation of prolonged antithrombotic pretreatment (“cooling-off” strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290:1593–1599.
77.
BraunwaldEAntmanEMBeasleyJW. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction–2002: summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002;106:1893–1900.
78.
MosesJWLeonMBPopmaJJ. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med.2003;349:1315–1323.
79.
MoriceMCSerruysPWSousaJE. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med.2002;346:1773–1780.
80.
StoneGWEllisSGCoxDA. A polymer-based, based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med.2004;350:221–231.
81.
HeubleinBRohdeRKaeseV. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?Heart. 2003;89:651–656.
82.
TamaiOMatsuokaHItabeH. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 1997;95:76–82.
83.
ColomboAKarvouniE. Biodegradable stents: “fulfilling the mission and stepping away.”Circulation. 2000;102:371–373.
84.
SchaarJAMullerJEFalkE. Terminology for high-risk and vulnerable coronary artery plaques. Eur Heart J.2004;25:1077–1082.
CribierAEltchaninoffHTronC. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698–703.
87.
CribierAEltchaninoffHBashA. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–3008.
